Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
It is generally agreed that patients with intermediate- or high-grade non-Hodgkin's lymphoma who have a relapse after initial therapy have a poor prognosis. 1 , 2 A retrospective study in 1984 from France and England showed a clear relation between the responsiveness of the lymphoma to treatmen...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 1995-12, Vol.333 (23), p.1540-1545 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1545 |
|---|---|
| container_issue | 23 |
| container_start_page | 1540 |
| container_title | The New England journal of medicine |
| container_volume | 333 |
| creator | Philip, Thierry Guglielmi, Cesare Hagenbeek, Anton Somers, Renier Van Der Lelie, Hans Bron, Dominique Sonneveld, Pieter Gisselbrecht, Christian Cahn, Jean-Yves Harousseau, Jean-Luc Coiffier, Bertrand Biron, Pierre Mandelli, Franco Chauvin, Franck |
| description | It is generally agreed that patients with intermediate- or high-grade non-Hodgkin's lymphoma who have a relapse after initial therapy have a poor prognosis.
1
,
2
A retrospective study in 1984 from France and England showed a clear relation between the responsiveness of the lymphoma to treatment and the outcome.
3
In 1987, the combination of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma in relapse was considered promising but experimental and appropriate for use only at research centers.
1
The value of that treatment remains an open question, because conventional salvage treatment without autologous bone marrow transplantation can induce . . . |
| doi_str_mv | 10.1056/NEJM199512073332305 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_223967982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9061783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-4ee98800f30020aee7c43d13335d689c2d1439adb0653e076df3aa52415b15623</originalsourceid><addsrcrecordid>eNp9kN1q20AQhZfSkDppn6AUllLoRVCyv5L2MjX5xUmhSa_FWBrZcrS76q6U4EfIW0fGJlAImZu5ON-c4RxCvnJ2zJlOT27Prm-4MZoLlkkphWT6A5lwLWWiFEs_kgljIk9UZuQnchDjio3Dldkn-5nKMp6aCXk-HXrf-oUfIv3lHdIbCME_0fsALnYtuB76xjsKkU697SBgRZ-afknvoH2EBdLpEq3vlxigW9PG0T_YQhcxUl__pyV36GLTN49Ib71LLn21eGjcz0hna9stvYXPZK-GNuKX3T4kf8_P7qeXyez3xdX0dJaUWuR9ohBNnjNWyzEcA8SsVLLiY35dpbkpRcWVNFDNWaolsiytagmgheJ6znUq5CH5vvXtgv83YOyLlR-CG18WQkiTZibfQHILlcHHGLAuutBYCOuCs2JTfvFG-ePVt531MLdYvd7s2h71HzsdYgltPXZcNvEVE4Zv_EbsaItZGwuHK_vu0xekmZlR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223967982</pqid></control><display><type>article</type><title>Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Philip, Thierry ; Guglielmi, Cesare ; Hagenbeek, Anton ; Somers, Renier ; Van Der Lelie, Hans ; Bron, Dominique ; Sonneveld, Pieter ; Gisselbrecht, Christian ; Cahn, Jean-Yves ; Harousseau, Jean-Luc ; Coiffier, Bertrand ; Biron, Pierre ; Mandelli, Franco ; Chauvin, Franck</creator><creatorcontrib>Philip, Thierry ; Guglielmi, Cesare ; Hagenbeek, Anton ; Somers, Renier ; Van Der Lelie, Hans ; Bron, Dominique ; Sonneveld, Pieter ; Gisselbrecht, Christian ; Cahn, Jean-Yves ; Harousseau, Jean-Luc ; Coiffier, Bertrand ; Biron, Pierre ; Mandelli, Franco ; Chauvin, Franck</creatorcontrib><description>It is generally agreed that patients with intermediate- or high-grade non-Hodgkin's lymphoma who have a relapse after initial therapy have a poor prognosis.
1
,
2
A retrospective study in 1984 from France and England showed a clear relation between the responsiveness of the lymphoma to treatment and the outcome.
3
In 1987, the combination of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma in relapse was considered promising but experimental and appropriate for use only at research centers.
1
The value of that treatment remains an open question, because conventional salvage treatment without autologous bone marrow transplantation can induce . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199512073332305</identifier><identifier>PMID: 7477169</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject><![CDATA[Adolescent ; Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Bone marrow ; Bone Marrow Transplantation ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Cancer ; Carmustine - administration & dosage ; Chemotherapy ; Cisplatin - administration & dosage ; Combined Modality Therapy ; Cyclophosphamide - administration & dosage ; Cytarabine - administration & dosage ; Dexamethasone - administration & dosage ; Etoposide - administration & dosage ; Female ; Humans ; Lymphatic system ; Lymphoma, Non-Hodgkin - drug therapy ; Lymphoma, Non-Hodgkin - mortality ; Lymphoma, Non-Hodgkin - radiotherapy ; Lymphoma, Non-Hodgkin - therapy ; Male ; Medical research ; Medical sciences ; Mesna - administration & dosage ; Middle Aged ; Prospective Studies ; Recurrence ; Salvage Therapy ; Survival Analysis ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation, Homologous ; Transplants & implants]]></subject><ispartof>The New England journal of medicine, 1995-12, Vol.333 (23), p.1540-1545</ispartof><rights>Copyright © 1995 Massachusetts Medical Society. All rights reserved.</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-4ee98800f30020aee7c43d13335d689c2d1439adb0653e076df3aa52415b15623</citedby><cites>FETCH-LOGICAL-c528t-4ee98800f30020aee7c43d13335d689c2d1439adb0653e076df3aa52415b15623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199512073332305$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/223967982?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,781,785,2760,2761,26108,27929,27930,52387,54069,64390,64394,72474</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2919512$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7477169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Philip, Thierry</creatorcontrib><creatorcontrib>Guglielmi, Cesare</creatorcontrib><creatorcontrib>Hagenbeek, Anton</creatorcontrib><creatorcontrib>Somers, Renier</creatorcontrib><creatorcontrib>Van Der Lelie, Hans</creatorcontrib><creatorcontrib>Bron, Dominique</creatorcontrib><creatorcontrib>Sonneveld, Pieter</creatorcontrib><creatorcontrib>Gisselbrecht, Christian</creatorcontrib><creatorcontrib>Cahn, Jean-Yves</creatorcontrib><creatorcontrib>Harousseau, Jean-Luc</creatorcontrib><creatorcontrib>Coiffier, Bertrand</creatorcontrib><creatorcontrib>Biron, Pierre</creatorcontrib><creatorcontrib>Mandelli, Franco</creatorcontrib><creatorcontrib>Chauvin, Franck</creatorcontrib><title>Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>It is generally agreed that patients with intermediate- or high-grade non-Hodgkin's lymphoma who have a relapse after initial therapy have a poor prognosis.
1
,
2
A retrospective study in 1984 from France and England showed a clear relation between the responsiveness of the lymphoma to treatment and the outcome.
3
In 1987, the combination of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma in relapse was considered promising but experimental and appropriate for use only at research centers.
1
The value of that treatment remains an open question, because conventional salvage treatment without autologous bone marrow transplantation can induce . . .</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone Marrow Transplantation</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Cancer</subject><subject>Carmustine - administration & dosage</subject><subject>Chemotherapy</subject><subject>Cisplatin - administration & dosage</subject><subject>Combined Modality Therapy</subject><subject>Cyclophosphamide - administration & dosage</subject><subject>Cytarabine - administration & dosage</subject><subject>Dexamethasone - administration & dosage</subject><subject>Etoposide - administration & dosage</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphatic system</subject><subject>Lymphoma, Non-Hodgkin - drug therapy</subject><subject>Lymphoma, Non-Hodgkin - mortality</subject><subject>Lymphoma, Non-Hodgkin - radiotherapy</subject><subject>Lymphoma, Non-Hodgkin - therapy</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Mesna - administration & dosage</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Recurrence</subject><subject>Salvage Therapy</subject><subject>Survival Analysis</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Transplantation, Homologous</subject><subject>Transplants & implants</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kN1q20AQhZfSkDppn6AUllLoRVCyv5L2MjX5xUmhSa_FWBrZcrS76q6U4EfIW0fGJlAImZu5ON-c4RxCvnJ2zJlOT27Prm-4MZoLlkkphWT6A5lwLWWiFEs_kgljIk9UZuQnchDjio3Dldkn-5nKMp6aCXk-HXrf-oUfIv3lHdIbCME_0fsALnYtuB76xjsKkU697SBgRZ-afknvoH2EBdLpEq3vlxigW9PG0T_YQhcxUl__pyV36GLTN49Ib71LLn21eGjcz0hna9stvYXPZK-GNuKX3T4kf8_P7qeXyez3xdX0dJaUWuR9ohBNnjNWyzEcA8SsVLLiY35dpbkpRcWVNFDNWaolsiytagmgheJ6znUq5CH5vvXtgv83YOyLlR-CG18WQkiTZibfQHILlcHHGLAuutBYCOuCs2JTfvFG-ePVt531MLdYvd7s2h71HzsdYgltPXZcNvEVE4Zv_EbsaItZGwuHK_vu0xekmZlR</recordid><startdate>19951207</startdate><enddate>19951207</enddate><creator>Philip, Thierry</creator><creator>Guglielmi, Cesare</creator><creator>Hagenbeek, Anton</creator><creator>Somers, Renier</creator><creator>Van Der Lelie, Hans</creator><creator>Bron, Dominique</creator><creator>Sonneveld, Pieter</creator><creator>Gisselbrecht, Christian</creator><creator>Cahn, Jean-Yves</creator><creator>Harousseau, Jean-Luc</creator><creator>Coiffier, Bertrand</creator><creator>Biron, Pierre</creator><creator>Mandelli, Franco</creator><creator>Chauvin, Franck</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>19951207</creationdate><title>Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma</title><author>Philip, Thierry ; Guglielmi, Cesare ; Hagenbeek, Anton ; Somers, Renier ; Van Der Lelie, Hans ; Bron, Dominique ; Sonneveld, Pieter ; Gisselbrecht, Christian ; Cahn, Jean-Yves ; Harousseau, Jean-Luc ; Coiffier, Bertrand ; Biron, Pierre ; Mandelli, Franco ; Chauvin, Franck</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-4ee98800f30020aee7c43d13335d689c2d1439adb0653e076df3aa52415b15623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone Marrow Transplantation</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Cancer</topic><topic>Carmustine - administration & dosage</topic><topic>Chemotherapy</topic><topic>Cisplatin - administration & dosage</topic><topic>Combined Modality Therapy</topic><topic>Cyclophosphamide - administration & dosage</topic><topic>Cytarabine - administration & dosage</topic><topic>Dexamethasone - administration & dosage</topic><topic>Etoposide - administration & dosage</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphatic system</topic><topic>Lymphoma, Non-Hodgkin - drug therapy</topic><topic>Lymphoma, Non-Hodgkin - mortality</topic><topic>Lymphoma, Non-Hodgkin - radiotherapy</topic><topic>Lymphoma, Non-Hodgkin - therapy</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Mesna - administration & dosage</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Recurrence</topic><topic>Salvage Therapy</topic><topic>Survival Analysis</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Transplantation, Homologous</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Philip, Thierry</creatorcontrib><creatorcontrib>Guglielmi, Cesare</creatorcontrib><creatorcontrib>Hagenbeek, Anton</creatorcontrib><creatorcontrib>Somers, Renier</creatorcontrib><creatorcontrib>Van Der Lelie, Hans</creatorcontrib><creatorcontrib>Bron, Dominique</creatorcontrib><creatorcontrib>Sonneveld, Pieter</creatorcontrib><creatorcontrib>Gisselbrecht, Christian</creatorcontrib><creatorcontrib>Cahn, Jean-Yves</creatorcontrib><creatorcontrib>Harousseau, Jean-Luc</creatorcontrib><creatorcontrib>Coiffier, Bertrand</creatorcontrib><creatorcontrib>Biron, Pierre</creatorcontrib><creatorcontrib>Mandelli, Franco</creatorcontrib><creatorcontrib>Chauvin, Franck</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Philip, Thierry</au><au>Guglielmi, Cesare</au><au>Hagenbeek, Anton</au><au>Somers, Renier</au><au>Van Der Lelie, Hans</au><au>Bron, Dominique</au><au>Sonneveld, Pieter</au><au>Gisselbrecht, Christian</au><au>Cahn, Jean-Yves</au><au>Harousseau, Jean-Luc</au><au>Coiffier, Bertrand</au><au>Biron, Pierre</au><au>Mandelli, Franco</au><au>Chauvin, Franck</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1995-12-07</date><risdate>1995</risdate><volume>333</volume><issue>23</issue><spage>1540</spage><epage>1545</epage><pages>1540-1545</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>It is generally agreed that patients with intermediate- or high-grade non-Hodgkin's lymphoma who have a relapse after initial therapy have a poor prognosis.
1
,
2
A retrospective study in 1984 from France and England showed a clear relation between the responsiveness of the lymphoma to treatment and the outcome.
3
In 1987, the combination of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma in relapse was considered promising but experimental and appropriate for use only at research centers.
1
The value of that treatment remains an open question, because conventional salvage treatment without autologous bone marrow transplantation can induce . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>7477169</pmid><doi>10.1056/NEJM199512073332305</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 1995-12, Vol.333 (23), p.1540-1545 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_journals_223967982 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Adolescent Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bone marrow Bone Marrow Transplantation Bone marrow, stem cells transplantation. Graft versus host reaction Cancer Carmustine - administration & dosage Chemotherapy Cisplatin - administration & dosage Combined Modality Therapy Cyclophosphamide - administration & dosage Cytarabine - administration & dosage Dexamethasone - administration & dosage Etoposide - administration & dosage Female Humans Lymphatic system Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - mortality Lymphoma, Non-Hodgkin - radiotherapy Lymphoma, Non-Hodgkin - therapy Male Medical research Medical sciences Mesna - administration & dosage Middle Aged Prospective Studies Recurrence Salvage Therapy Survival Analysis Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation, Homologous Transplants & implants |
| title | Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T21%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autologous%20Bone%20Marrow%20Transplantation%20as%20Compared%20with%20Salvage%20Chemotherapy%20in%20Relapses%20of%20Chemotherapy-Sensitive%20Non-Hodgkin's%20Lymphoma&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Philip,%20Thierry&rft.date=1995-12-07&rft.volume=333&rft.issue=23&rft.spage=1540&rft.epage=1545&rft.pages=1540-1545&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM199512073332305&rft_dat=%3Cproquest_cross%3E9061783%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223967982&rft_id=info:pmid/7477169&rfr_iscdi=true |